NewsRx

Search our medical news database

Maas Biolab, LLC

Maas Biolab receives $50,000 grant to develop cyclosporin neuroprotection products

Published in Mental Health Business Week, May 27th, 2006

The Fort Detrick Technology Transfer Initiative (FDTTI) managed by the Maryland Technology Development Corporation (TEDCO) has awarded $50,000 to Maas Biolab, LLC to continue development of its cyclosporin neuroprotection products.

Funding for the FDTTI is provided by the United States Congress.

Maas Biolab, LLC is developing proprietary cyclosporin formulations for the treatment of battlefield traumatic brain injury and nerve agent exposure. This FDTTI grant will speed development of these cyclosporin formulations, which are being tested at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland, by Drs. Richard A. Bauman and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook